title: A modified screening system for loss-of-function and dominant negative alleles of essential MCMV genes.
abstract: Inactivation of gene products by dominant negative mutants is a valuable tool to assign functions to yet uncharacterized proteins, to map protein-protein interactions or to dissect physiological pathways. Detailed functional and structural knowledge about the target protein would allow the construction of inhibitory mutants by targeted mutagenesis. Yet, such data are limited for the majority of viral proteins, so that the target gene needs to be subjected to random mutagenesis to identify suitable mutants. However, for cytomegaloviruses this requires a two-step screening approach, which is time-consuming and labor-intensive. Here, we report the establishment of a high-throughput suitable screening system for the identification of inhibitory alleles of essential genes of the murine cytomegalovirus (MCMV). In this screen, the site-specific recombination of a specifically modified MCMV genome was transferred from the bacterial background to permissive host cells, thereby combining the genetic engineering and the rescue test in one step. Using a reference set of characterized pM53 mutants it was shown that the novel system is applicable to identify non-complementing as well as inhibitory mutants in a high-throughput suitable setup. The new cis-complementation assay was also applied to a basic genetic characterization of pM99, which was identified as essential for MCMV growth. We believe that the here described novel genetic screening approach can be adapted for the genetic characterization of essential genes of any large DNA viruses.
authors.affiliation: Max von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Munich, Germany; DZIF - German Center for Infection Research, Munich, Germany.
authors.forename: Madlen
authors.initials: M
authors.lastname: Pogoda
authors.affiliation: Max von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Munich, Germany.
authors.forename: Jens B
authors.initials: JB
authors.lastname: Bosse
authors.affiliation: Max von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Munich, Germany.
authors.forename: Karl-Klaus
authors.initials: KK
authors.lastname: Conzelmann
authors.affiliation: Max von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Munich, Germany.
authors.forename: Ulrich H
authors.initials: UH
authors.lastname: Koszinowski
authors.affiliation: Max von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Munich, Germany; DZIF - German Center for Infection Research, Munich, Germany.
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Ruzsics
mesh_terms: D000483:Alleles; D000818:Animals; D004254:DNA Nucleotidyltransferases / Q000378:metabolism; D005799:Genes, Dominant; D020043:Genes, Essential; D005814:Genes, Viral; D005816:Genetic Complementation Test; D005820:Genetic Testing / Q000379:methods*; D051379:Mice; D018146:Muromegalovirus / Q000235:genetics*; D009154:Mutation / Q000235:genetics; D041681:NIH 3T3 Cells; D015203:Reproducibility of Results; D014764:Viral Proteins / Q000378:metabolism
chemical_list: D014764:Viral Proteins; D004254:DNA Nucleotidyltransferases; C045119:FLP recombinase
references.citation: Hum Gene Ther. 1998 Dec 10;9(18):2787-94
references.pmid: 9874276
references.citation: J Virol. 2005 Jan;79(1):486-94
references.pmid: 15596841
references.citation: J Virol. 2011 Sep;85(18):9254-67
references.pmid: 21715482
references.citation: J Virol. 2012 Dec;86(23):12512-24
references.pmid: 22993161
references.citation: J Virol. 2007 Jun;81(12):6536-47
references.pmid: 17392372
references.citation: J Virol. 1985 Aug;55(2):264-73
references.pmid: 2991554
references.citation: Nucleic Acids Res. 2005 Feb 24;33(4):e36
references.pmid: 15731329
references.citation: Anticancer Res. 2002 Nov-Dec;22(6A):3325-30
references.pmid: 12530082
references.citation: J Virol. 2004 Feb;78(3):1488-502
references.pmid: 14722304
references.citation: Nat Methods. 2012 Jul;9(7):671-5
references.pmid: 22930834
references.citation: J Virol. 2000 Aug;74(15):6964-74
references.pmid: 10888635
references.citation: J Virol. 1992 Aug;66(8):5168-74
references.pmid: 1321297
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14223-8
references.pmid: 14623981
references.citation: BMC Biotechnol. 2010 Feb 08;10:9
references.pmid: 20144189
references.citation: Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12396-401
references.pmid: 14519856
references.citation: J Virol. 2003 May;77(9):5339-51
references.pmid: 12692236
references.citation: PLoS Pathog. 2012;8(6):e1002728
references.pmid: 22685399
references.citation: Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14759-63
references.pmid: 9405686
references.citation: J Virol. 1999 Oct;73(10):8320-9
references.pmid: 10482582
references.citation: J Virol. 2007 Nov;81(22):12654-65
references.pmid: 17855513
references.citation: J Bacteriol. 1986 Feb;165(2):341-7
references.pmid: 3003022
references.citation: J Virol. 2012 Sep;86(18):9647-55
references.pmid: 22740416
references.citation: Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8245-50
references.pmid: 9653172
references.citation: J Virol. 1998 Jan;72(1):48-56
references.pmid: 9420199
references.citation: Curr Top Microbiol Immunol. 1975;70:51-100
references.pmid: 1098857
references.citation: J Virol. 2006 Dec;80(23):11658-66
references.pmid: 17005637
references.citation: Curr Opin Biotechnol. 2001 Oct;12(5):473-80
references.pmid: 11604323
references.citation: J Virol. 1993 Jun;67(6):3470-80
references.pmid: 8388510
references.citation: Curr Protoc Mol Biol. 2005 May;Chapter 28:Unit 28.1
references.pmid: 18265366
references.citation: J Virol. 2006 Jun;80(11):5611-26
references.pmid: 16699042
references.citation: Viruses. 2009 Dec;1(3):420-40
references.pmid: 21994555
references.citation: Gene Ther. 2000 May;7(10):875-85
references.pmid: 10845726
references.citation: J Neurosci Methods. 2012 Aug 15;209(2):420-7
references.pmid: 22750652
references.citation: J Virol. 2010 Sep;84(18):9035-46
references.pmid: 20610730
references.citation: J Virol. 2009 Jan;83(1):47-57
references.pmid: 18945788
references.citation: Nature. 1987 Sep 17-23;329(6136):219-22
references.pmid: 2442619
references.citation: Curr Top Microbiol Immunol. 2008;325:41-61
references.pmid: 18637499
references.citation: Gene. 1995 May 26;158(1):9-14
references.pmid: 7789817
references.citation: Viruses. 2012 Feb;4(2):211-35
references.pmid: 22470833
references.citation: Nat Biotechnol. 1998 Jul;16(7):657-62
references.pmid: 9661200
references.citation: J Virol. 2006 Aug;80(16):8100-13
references.pmid: 16873266
references.citation: J Virol. 2003 May;77(10):5557-70
references.pmid: 12719548
references.citation: J Virol. 2004 Jan;78(1):539-43
references.pmid: 14671136
references.citation: Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2081-6
references.pmid: 15684067
references.citation: J Immunol Methods. 2003 Mar 1;274(1-2):245-56
references.pmid: 12609550
references.citation: J Virol. 2004 Aug;78(15):8026-35
references.pmid: 15254174
references.citation: J Virol. 2007 Jun;81(11):5508-17
references.pmid: 17376929
references.citation: Trends Microbiol. 2002 Jul;10(7):318-24
references.pmid: 12110210
references.citation: J Virol. 2003 Oct;77(19):10594-605
references.pmid: 12970444
references.citation: Virology. 2009 May 25;388(1):68-77
references.pmid: 19345970
references.citation: J Virol. 2006 Jan;80(1):73-84
references.pmid: 16352532
references.citation: J Virol. 1999 Aug;73(8):6405-14
references.pmid: 10400733
references.citation: J Gen Virol. 1992 Mar;73 ( Pt 3):539-47
references.pmid: 1312117